LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | Dasatinib | 0.04 | uM | LJP5 | 1 | D06 | 72 | hr | 1389 | 3551 | 5772 | 0.6152 | 0.5789 |
| MCF7 | Dasatinib | 0.04 | uM | LJP5 | 3 | D06 | 72 | hr | 1389 | 4128 | 6038 | 0.6836 | 0.6715 |
| MCF7 | Dasatinib | 0.12 | uM | LJP6 | 1 | I05 | 72 | hr | 1389 | 1026 | 5147 | 0.1993 | -0.1481 |
| MCF7 | Dasatinib | 0.12 | uM | LJP6 | 2 | I05 | 72 | hr | 1389 | 1144 | 5447 | 0.2100 | -0.0938 |
| MCF7 | Dasatinib | 0.12 | uM | LJP6 | 3 | I05 | 72 | hr | 1389 | 1122 | 5740 | 0.1955 | -0.0990 |
| MCF7 | Dasatinib | 0.12 | uM | LJP5 | 1 | D05 | 72 | hr | 1389 | 1782 | 5772 | 0.3087 | 0.1289 |
| MCF7 | Dasatinib | 0.12 | uM | LJP5 | 3 | D05 | 72 | hr | 1389 | 1862 | 6038 | 0.3084 | 0.1482 |
| MCF7 | Dasatinib | 0.37 | uM | LJP6 | 1 | I04 | 72 | hr | 1389 | 912 | 5147 | 0.1772 | -0.1996 |
| MCF7 | Dasatinib | 0.37 | uM | LJP6 | 2 | I04 | 72 | hr | 1389 | 1093 | 5447 | 0.2006 | -0.1145 |
| MCF7 | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 1389 | 1079 | 5740 | 0.1880 | -0.1161 |
| MCF7 | Dasatinib | 0.37 | uM | LJP5 | 1 | D04 | 72 | hr | 1389 | 1141 | 5772 | 0.1977 | -0.0913 |
| MCF7 | Dasatinib | 0.37 | uM | LJP5 | 3 | D04 | 72 | hr | 1389 | 1019 | 6038 | 0.1688 | -0.1360 |
| MCF7 | Dasatinib | 1.11 | uM | LJP6 | 1 | I03 | 72 | hr | 1389 | 961 | 5147 | 0.1867 | -0.1771 |
| MCF7 | Dasatinib | 1.11 | uM | LJP6 | 2 | I03 | 72 | hr | 1389 | 1048 | 5447 | 0.1924 | -0.1332 |
| MCF7 | Dasatinib | 1.11 | uM | LJP6 | 3 | I03 | 72 | hr | 1389 | 1070 | 5740 | 0.1864 | -0.1197 |
| MCF7 | Dasatinib | 1.11 | uM | LJP5 | 1 | D03 | 72 | hr | 1389 | 927 | 5772 | 0.1606 | -0.1786 |
| MCF7 | Dasatinib | 1.11 | uM | LJP5 | 3 | D03 | 72 | hr | 1389 | 948 | 6038 | 0.1570 | -0.1649 |
| MCF7 | Dasatinib | 3.33 | uM | LJP6 | 1 | I02 | 72 | hr | 1389 | 925 | 5147 | 0.1797 | -0.1936 |
| MCF7 | Dasatinib | 3.33 | uM | LJP6 | 2 | I02 | 72 | hr | 1389 | 1087 | 5447 | 0.1995 | -0.1170 |
| MCF7 | Dasatinib | 3.33 | uM | LJP6 | 3 | I02 | 72 | hr | 1389 | 1128 | 5740 | 0.1965 | -0.0967 |
| MCF7 | Dasatinib | 3.33 | uM | LJP5 | 1 | D02 | 72 | hr | 1389 | 1025 | 5772 | 0.1776 | -0.1375 |
| MCF7 | Dasatinib | 3.33 | uM | LJP5 | 3 | D02 | 72 | hr | 1389 | 997 | 6038 | 0.1651 | -0.1448 |
| MCF7 | Dasatinib | 10 | uM | LJP6 | 1 | I01 | 72 | hr | 1389 | 768 | 5147 | 0.1492 | -0.2692 |
| MCF7 | Dasatinib | 10 | uM | LJP6 | 2 | I01 | 72 | hr | 1389 | 847 | 5447 | 0.1555 | -0.2219 |
| MCF7 | Dasatinib | 10 | uM | LJP6 | 3 | I01 | 72 | hr | 1389 | 881 | 5740 | 0.1535 | -0.1994 |